Publicaciones (18) Publicaciones de RUBA AL ABDULLA

2024

  1. Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma

    Gastroenterology, Vol. 166, Núm. 5, pp. 886-901.e7

  2. SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer

    Cell Reports, Vol. 43, Núm. 3

2023

  1. Exploring the Effects of Metabolism-Disrupting Chemicals on Pancreatic α-Cell Viability, Gene Expression and Function: A Screening Testing Approach

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  2. Immunogenic cell death triggered by impaired deubiquitination in multiple myeloma relies on dysregulated type I interferon signaling

    Frontiers in Immunology, Vol. 14

  3. Role of organic cation transporter 3 (OCT3) in the response of hepatocellular carcinoma to tyrosine kinase inhibitors

    Biochemical Pharmacology, Vol. 217

  4. The Role of the Ectopeptidase APN/CD13 in Cancer

    Biomedicines, Vol. 11, Núm. 3

2020

  1. Bisphenol-A exposure during pregnancy alters pancreatic β-cell division and mass in male mice offspring: A role for ERβ

    Food and Chemical Toxicology, Vol. 145

  2. Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 5

  3. Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters

    Biochemical Pharmacology, Vol. 171

2019

  1. Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy

    Hepatology, Vol. 70, Núm. 4, pp. 1246-1261

  2. Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

    British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800

  3. Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas

    Acta neuropathologica communications, Vol. 7, Núm. 1, pp. 201

  4. Unraveling ‘The Cancer Genome Atlas’ information on the role of SLC transporters in anticancer drug uptake

    Expert Review of Clinical Pharmacology, Vol. 12, Núm. 4, pp. 329-341

  5. What “The Cancer Genome Atlas” database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 15, Núm. 7, pp. 577-593

2017

  1. Molecular bases of chemoresistance in cholangiocarcinoma

    Current Drug Targets, Vol. 18, Núm. 8, pp. 889-900

  2. Suitability of small diagnostic peripheral-blood samples for cell-therapy studies

    Cytotherapy, Vol. 19, Núm. 2, pp. 311-326

  3. The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma

    Oncotarget, Vol. 8, Núm. 9, pp. 15846-15857

2016

  1. Mechanisms of resistance to chemotherapy in gastric cancer

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 16, Núm. 3, pp. 318-334